Device
contrast enhanced ultrasonography
contrast enhanced ultrasonography is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
unknown1
Withdrawn1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
withdrawn133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
NCT02733029
withdrawnnot_applicable
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
NCT01426724
unknown
Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization
NCT00351494
Clinical Trials (3)
Showing 3 of 3 trials
NCT02733029Phase 2
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
NCT01426724Not Applicable
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
NCT00351494
Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3